•   
  •   

World Pfizer, Moderna to raise prices for Europe: Report

08:11  02 august  2021
08:11  02 august  2021 Source:   aljazeera.com

GPs in Sydney confused by Pfizer COVID-19 vaccine distribution, which they say has not targeted hotspots

  GPs in Sydney confused by Pfizer COVID-19 vaccine distribution, which they say has not targeted hotspots NSW Chief Health Officer Kerry Chant advocates for more Pfizer to be made available in Sydney's hotspots as some GPs say Pfizer distribution has not prioritised the areas worst affected by the outbreak.They are worried it means the sought-after jab is not going where it is needed most, such as the current COVID-19 hotspots in western Sydney.

Pfizer and Moderna, the manufacturers of two of the most effective COVID-19 vaccines, have raised the prices of their jabs in their latest European Union (EU) supply contracts, according to a report in the Financial Times (FT).

a man and a woman standing in a room: Pfizer and Moderna are said to be raising the price of their COVID-19 vaccines in Europe [File: Leon Kuegeler/Reuters] © Provided by Al Jazeera Pfizer and Moderna are said to be raising the price of their COVID-19 vaccines in Europe [File: Leon Kuegeler/Reuters]

The new price for the Pfizer shot was 19.50 euros ($23.15) compared with 15.50 euros ($18.39) previously, the newspaper said, citing portions of the contracts it had seen.

The price of a dose of the Moderna vaccine was set at $25.50, according to the contracts, compared with $22.60 in the first procurement deal, although lower than the previously agreed $28.50 because the order was larger, the FT said, citing one official close to the matter.

PM won't disrupt national rollout for NSW

  PM won't disrupt national rollout for NSW Despite NSW pleas for redirected Pfizer vaccines, the prime minister has instead backed delayed second doses to enable Sydneysiders to at least get one.However, the prime minister has backed lengthening the time between precious Pfizer doses to ensure younger people in the city's worst-affected suburbs at least get one dose.

Al Jazeera’s Neave Barker, who is in London, said the price hikes reflected the continued demand for effective jabs and that governments had become a “captive audience” to pharmaceutical companies.

“EU countries are keen to stamp out the spread of the Delta variant,” he said. “And the EU and countries beyond are mulling the possibility of administering a booster jab to improve efficacy.”

Pfizer declined to comment on the contract with the European Commission (EC), citing confidentiality. “Beyond the redacted contract(s) published by the EC, the content remains confidential and so we won’t be commenting,” the company said.

a person standing in front of a window: The UK is also set to offer third doses from September, according to a report in the Daily Telegraph newspaper [Henry Nicholls/Reuters] © Provided by Al Jazeera The UK is also set to offer third doses from September, according to a report in the Daily Telegraph newspaper [Henry Nicholls/Reuters]

Moderna was not immediately available for comment to the Reuters news agency.

The Pfizer COVID-19 vaccine has been approved for kids aged 12-15. Here's what happens next

  The Pfizer COVID-19 vaccine has been approved for kids aged 12-15. Here's what happens next Australia's medicines regulator has approved the Pfizer COVID-19 vaccine for young teenagers, but experts say it'll be some time yet before most kids are included in the wider vaccine rollout. Now that the Therapeutic Goods Administration (TGA) has decided the vaccine is safe for 12 to 15-year-olds, it's up to another group, the Australian Technical Advisory Group on Immunisation (ATAGI), to decide how and when younger people should get the vaccine.So when will most children get the vaccine, how effective is it, and does this approval mean adults have to wait?Here are some of your common questions answered.

Last Tuesday, the European Commission said that the EU is on course to hit a target of fully vaccinating at least 70 percent of the adult population by the end of September. In May, the EU said it expects to have received more than a billion doses of vaccines by that time from four drugmakers.

The World Health Organization has urged wealthy countries to share vaccine doses rather than go for booster shots, as new outbreaks gather pace in countries in Asia and Africa, where a far smaller proportion of the population has had access to vaccinations.

Israel has begun to offer booster shots to people in their 60s and older, and the United Kingdom might start giving out booster shots next month, according to the Daily Telegraph newspaper.

Germany might also start offering boosters to the elderly and at-risk from September 1, according to a draft document seen by the AFP news agency, which also recommends promoting vaccination for those aged 12 to 17.

Health Minister Jens Spahn and Germany’s 16 regional health ministers are expected to finalise the plans in a meeting on Monday.

Moderna vaccine to be approved within a fortnight, doses rolling out in mid-September .
Federal Health Minister Greg Hunt says he expects the national rollout of the Moderna vaccine to begin from the middle of next month, with the TGA set to approve the vaccine shortly.The Moderna vaccine is currently being considered by the Therapeutic Goods Administration (TGA), and Health Minister Greg Hunt said he expected it to be approved shortly.

usr: 0
This is interesting!